Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
在病毒学抑制的 HIV 感染青少年中，口服和长效注射卡博特韦或长效注射利匹韦林的安全性和药代动力学研究（IMPAACT 2017/MOCHA）：一项 1/2 期、多中心、开放标签、非对照、剂量探索性研究
期刊:Lancet HIV
影响因子:
doi:10.1016/S2352-3018(23)00300-4
Gaur, Aditya H; Capparelli, Edmund V; Calabrese, Katherine; Baltrusaitis, Kristin; Marzinke, Mark A; McCoig, Cynthia; Van Solingen-Ristea, Rodica M; Mathiba, Sisinyana Ruth; Adeyeye, Adeola; Moye, John H; Heckman, Barbara; Lowenthal, Elizabeth D; Ward, Shawn; Milligan, Ryan; Samson, Pearl; Best, Brookie M; Harrington, Conn M; Ford, Susan L; Huang, Jenny; Crauwels, Herta; Vandermeulen, Kati; Agwu, Allison L; Smith-Anderson, Christiana; Camacho-Gonzalez, Andres; Ounchanum, Pradthana; Kneebone, Jared L; Townley, Ellen; Bolton Moore, Carolyn
